398 related articles for article (PubMed ID: 19342961)
1. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes.
Li T; Wang Y; Liu C; Hu Y; Wu M; Li J; Guo L; Chen L; Chen Q; Ha T; Li C; Li Y
J Hypertens; 2009 May; 27(5):1084-93. PubMed ID: 19342961
[TBL] [Abstract][Full Text] [Related]
2. [Role of MyD88-dependent nuclear factor-kappaB signaling pathway in the development of cardiac hypertrophy in vivo].
Li YH; Ha TZ; Chen Q; Li CF
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):267-72. PubMed ID: 15854490
[TBL] [Abstract][Full Text] [Related]
3. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
[TBL] [Abstract][Full Text] [Related]
4. Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling.
Ando K; Hasegawa K; Shindo K; Furusawa T; Fujino T; Kikugawa K; Nakano H; Takeuchi O; Akira S; Akiyama T; Gohda J; Inoue J; Hayakawa M
FEBS J; 2010 May; 277(9):2051-66. PubMed ID: 20345905
[TBL] [Abstract][Full Text] [Related]
5. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
[TBL] [Abstract][Full Text] [Related]
6. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
Qin J; Liu ZX
Acta Pharmacol Sin; 2006 Sep; 27(9):1159-64. PubMed ID: 16923336
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
8. Acrolein with an alpha, beta-unsaturated carbonyl group inhibits LPS-induced homodimerization of toll-like receptor 4.
Lee JS; Lee JY; Lee MY; Hwang DH; Youn HS
Mol Cells; 2008 Apr; 25(2):253-7. PubMed ID: 18414004
[TBL] [Abstract][Full Text] [Related]
9. Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes.
Tian J; Guo X; Liu XM; Liu L; Weng QF; Dong SJ; Knowlton AA; Yuan WJ; Lin L
Cardiovasc Res; 2013 Jun; 98(3):391-401. PubMed ID: 23447644
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
11. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice.
Gao Y; Fang X; Tong Y; Liu Y; Zhang B
Biomed Pharmacother; 2009 Jul; 63(6):442-50. PubMed ID: 18804339
[TBL] [Abstract][Full Text] [Related]
12. FAK signalling mediates NF-kappaB activation by mechanical stress in cardiac myocytes.
Crosara-Alberto DP; Inoue RY; Costa CR
Clin Chim Acta; 2009 May; 403(1-2):81-6. PubMed ID: 19361463
[TBL] [Abstract][Full Text] [Related]
13. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway.
Ikebe M; Kitaura Y; Nakamura M; Tanaka H; Yamasaki A; Nagai S; Wada J; Yanai K; Koga K; Sato N; Kubo M; Tanaka M; Onishi H; Katano M
J Surg Oncol; 2009 Dec; 100(8):725-31. PubMed ID: 19722233
[TBL] [Abstract][Full Text] [Related]
15. Discovering differential activation machinery of the Toll-like receptor 4 signaling pathways in MyD88 knockouts.
Selvarajoo K
FEBS Lett; 2006 Feb; 580(5):1457-64. PubMed ID: 16458306
[TBL] [Abstract][Full Text] [Related]
16. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
17. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy.
Kashiwase K; Higuchi Y; Hirotani S; Yamaguchi O; Hikoso S; Takeda T; Watanabe T; Taniike M; Nakai A; Tsujimoto I; Matsumura Y; Ueno H; Nishida K; Hori M; Otsu K
Biochem Biophys Res Commun; 2005 Feb; 327(1):136-42. PubMed ID: 15629441
[TBL] [Abstract][Full Text] [Related]
18. Two neisseria meningitidis strains with different ability to stimulate toll-like receptor 4 through the MyD88-independent pathway.
Mogensen TH; Paludan SR; Kilian M; Østergaard L
Scand J Immunol; 2006 Dec; 64(6):646-54. PubMed ID: 17083621
[TBL] [Abstract][Full Text] [Related]
19. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.
Planavila A; Rodríguez-Calvo R; de Arriba AF; Sánchez RM; Laguna JC; Merlos M; Vazquez-Carrera M
Mol Pharmacol; 2006 Apr; 69(4):1174-81. PubMed ID: 16421291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
